Aurinia Pharmaceuticals's total assets for Q2 2025 were $502.56M, a decrease of -0.45% from the previous quarter. AUPH total liabilities were $167.26M for the fiscal quarter, a 8.15% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.